ArticleCancers2024

Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation.

Gunnar Weise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.